A Study of Different Use Regimens Using Two Acne Treatments

Inclusion Criteria: * Males and non-pregnant or non-nursing females, 12 years or older, with facial acne vulgaris; * Minimum of 20 but no more than 50 inflammatory lesions (papules and pustules); * Minimum of 30 but no more than 100 facial non-inflammatory lesions (open and closed comedones); * Must have at least a rating of grade 3 on the Investigator Global severity scale at baseline Exclusion Criteria: * Known sensitivity to any of the ingredients in the study medication; * Any nodulocystic acne lesions; * Use of acne devices or systemic therapy with antibiotics within two months prior to start and throughout the duration of the study; * Use of systemic therapy with retinoids within four months prior to study start and throughout the duration of the study; * Topical use of retinoids within two weeks prior to study start and throughout the duration of the study; * Topical use of antibiotics, steroids and/or other non-retinoid topical acne products within two weeks prior to study start and throughout the duration of the study; * If subject is taking birth control pills, she must be stabilized for at least three months prior to study start; * History of evidence of other skin conditions or diseases that may require concurrent therapy or may interfere with the evaluation of the study medication; * Any significant medical conditions that could confound the interpretation of the study; * Excessive facial hair that may interfere with evaluations; * No use of tanning booths, sun lamps, etc.